Search Results for "Ondansetron For Alcohol Cessation"
Original Source: Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults
This study will evaluate the efficacy of ondansetron + BASICS Plus in reducing severe or binge drinking among emerging adults. BASIC Plus (Brief Alcohol Screening and Intervention for College Students) has been the most validated brief intervention among college students. The BASICS program provides personal feedback, motivation, and strategies that enhance normative drinking patterns
Matching Channels
Because of the addictive properties of components of cigarettes, giving up the habit of smoking is often very hard. It is often required however for health reasons. There is a lot of publicity of...
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyle...
Gastroesophageal Reflux Disease GERD
GERD is a condition which develops when the reflux of stomach contents causes troublesome symptoms (ie at least two heartburns per week) and/or complications. Predisposing factors include dysfunctio...
Matching News
The U.S. Food and Drug Administration (FDA) is notifying health care professionals that the 32 mg, single intravenous (IV) dose of the antinausea drug Zofran (ondansetron hydrochloride) will no longer...
FDA: Single IV dose of ondansetron may cause potentially fatal heart rhythms
FDA is alerting healthcare professionals to the possibility that a 32-mg single intravenous dose of ondansetron (Zofran, ondansetron hydrochloride, and generics) could lead to QT interval prolonga...
Sagent unveils Ondansetron Injection, USP
Sagent Pharmaceuticals, a specialty pharmaceutical company, has launched Ondansetron Injection, USP, an antiemetic, in two latex-free vial presentations.
Ondansetron Safe for Fetus, Study Affirms (CME/CE)
(MedPage Today) -- Use of the antiemetic ondansetron during pregnancy was not associated with any adverse fetal outcomes, an observational study showed.
FDA Drug Safety Communication: New information regarding QT prolongation with ondansetron (Zofran)
The U.S. Food and Drug Administration (FDA) is informing healthcare professionals and the public that preliminary results from a recently completed clinical study suggest that a 32 mg single intraveno...
Is Ondansetron Safe for Preventing Vomiting in Pregnancy?
Andrew Kaunitz, MD, comments on the recent study showing that ondansetron does not have significant adverse effects on the fetus when used to prevent vomiting. Medscape Ob/Gyn
Ondansetron looks safe in pregnancy, so far
N Engl J Med2013;368:814-23The popular antiemetic ondansetron looked safe for pregnant women in a large study from Denmark. The authors found no evidence of harm to the unborn baby in a series of......
Ondansetron Not Associated With Adverse Fetal Events
A population-based Danish study has found no association between the use of ondansetron during pregnancy and adverse fetal events. Medscape Medical News
Matching PubMed Articles
RATIONALE: Alcohol dependence is the third leading cause of preventable death in the USA. While single-agent pharmacotherapies have variable efficacy, medication combinations may produce additive effe...
Harmful alcohol use is a risk factor in more than 60 diseases and injuries resulting in approximately 2.5 million deaths per year worldwide. In the United States (US) and Europe, there are only a few...
Introduction: Ondansetron is a 5-HT3 receptor antagonist commonly used as an antiemetic to prevent nausea and vomiting associated with anti-cancer drugs, cancer radiotherapy or postoperatively. Recent...
PURPOSE: The purpose of this study was to compare the efficacy of ondansetron and metoclopramide, administered for the prophylaxis of vomiting in patients undergoing oral and maxillofacial surgery und...
Psychostimulant abuse represents a psychiatric disorder and societal concern that has been largely unamenable to therapeutic interventions. We have previously demonstrated that the 5-HT₃ antagonist...
